Hyloris Pharmaceuticals (XBRU:HYL) PB Ratio : 8.44 (As of May. 02, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Hyloris Pharmaceuticals PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-02), Hyloris Pharmaceuticals's share price is €11.70. Hyloris Pharmaceuticals's Book Value per Share for the quarter that ended in Dec. 2023 was €1.39. Hence, Hyloris Pharmaceuticals's PB Ratio of today is 8.44.

The historical rank and industry rank for Hyloris Pharmaceuticals's PB Ratio or its related term are showing as below:

XBRU:HYL' s PB Ratio Range Over the Past 10 Years
Min: 4.16 Med: 6.68 Max: 10.78
Current: 8.44

During the past 8 years, Hyloris Pharmaceuticals's highest PB Ratio was 10.78. The lowest was 4.16. And the median was 6.68.

XBRU:HYL's PB Ratio is ranked worse than
87.8% of 1311 companies
in the Biotechnology industry
Industry Median: 2.46 vs XBRU:HYL: 8.44

During the past 12 months, Hyloris Pharmaceuticals's average Book Value Per Share Growth Rate was -29.50% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -15.40% per year.

During the past 8 years, the highest 3-Year average Book Value Per Share Growth Rate of Hyloris Pharmaceuticals was -15.40% per year. The lowest was -15.40% per year. And the median was -15.40% per year.

Back to Basics: PB Ratio

Hyloris Pharmaceuticals PB Ratio Historical Data

The historical data trend for Hyloris Pharmaceuticals's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hyloris Pharmaceuticals PB Ratio Chart

Hyloris Pharmaceuticals Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

PB Ratio

Get a 7-Day Free Trial

4.16

10.08

5.90

9.20

Hyloris Pharmaceuticals Semi-Annual Data
	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
PB Ratio	Get a 7-Day Free Trial							10.08	6.86	5.90	6.29	9.20

Competitive Comparison of Hyloris Pharmaceuticals's PB Ratio

For the Biotechnology subindustry, Hyloris Pharmaceuticals's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hyloris Pharmaceuticals's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hyloris Pharmaceuticals's PB Ratio distribution charts can be found below:

* The bar in red indicates where Hyloris Pharmaceuticals's PB Ratio falls into.

Hyloris Pharmaceuticals PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Hyloris Pharmaceuticals's PB Ratio for today is calculated as follows:

PB Ratio	=	Share Price	/	Book Value per Share (Q: Dec. 2023)
	=	11.70	/	1.386
	=	8.44

It can also be calculated from the numbers for the whole company:

PB Ratio

Market Cap

(Total Stockholders Equity

Preferred Stock)

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Hyloris Pharmaceuticals (XBRU:HYL) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.

Hyloris Pharmaceuticals PB Ratio Related Terms

Thank you for viewing the detailed overview of Hyloris Pharmaceuticals's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Hyloris Pharmaceuticals (XBRU:HYL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hyloris Pharmaceuticals SA (XBRU:HYL) » Definitions » PB Ratio

Comparable Companies

Traded in Other Exchanges

52U:Germany

Address

Boulevard Patience et Beaujonc N°3/1, Liege, BEL, 4000

Website

https://www.hyloris.com

Hyloris Pharmaceuticals SA is an early-stage specialty pharmaceutical company focused on adding value to the healthcare system by reformulating pharmaceuticals. The company develops proprietary products it believes offer advantages compared to available alternatives, to address the underserved medical needs of patients, hospitals, physicians, payors, and other stakeholders in the healthcare system. Its portfolio spans these areas such as Cardiovascular, Other Reformulations, and Established markets (high-barrier generics). It has two early commercial-stage products, Sotalol IV for the treatment of atrial fibrillation, and Maxigesic IV, a non-opioid analgesic product for the treatment of pain.